« Previous
Next »
American Journal of Obstetrics & Gynecology
Volume 182, Issue 1
, Pages 41-49
, January 2000
A novel intermittent regimen of norgestimate to preserve the beneficial effects of 17β-estradiol on lipid and lipoprotein profiles
References
-
.
1997 Heart and stroke statistical update.
Dallas: The Association; 1997;
- . Estrogen replacement therapy and cardiovascular protection: lipid mechanisms are the tip of an iceberg. Gynecol Endocrinol. 1998;12:43–59
-
.
Cardioprotection by estrogens: mechanisms of action—the lipids.
Int J Fertil Menopausal Stud. 1994;39(Suppl 1):43–49
- . Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT). Lancet. 1998;352:1965–1969
- . Cardiovascular disease in postmenopausal women. Maturitas. 1998;30:11–18
- . Postmenopausal hormone therapy. Is it useful for coronary prevention?. Cardiol Clin. 1998;16:17–25
- . Lipids and lipoproteins in women. Mayo Clin Proc. 1997;72:235–244
- . The menopause and hormone replacement therapy: lipids, lipoproteins, coagulation and fibrinolytic factors. Maturitas. 1996;23:209–216
- . Lipids, atherosclerosis, and the postmenopausal woman: a clinical perspective. Obstet Gynecol Clin North Am. 1994;21:337–355
- . Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. J Clin Endocrinol Metab. 1991;73:925–930
- . Endometrial histology and biochemistry in climacteric women during oestrogen and oestrogen/progestogen therapy. J R Soc Med. 1979;72:322–327
- . Relations between bleeding pattern, endometrial histology, and oestrogen treatment in menopausal women. BMJ. 1978;1:1575–1577
- . The effects of oestrogens and progestogens on the postmenopausal endometrium. Maturitas. 1978;1:87–98
- Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. BMJ. 1989;298:147–151
- . Endometrial hyperplasia in women on cyclic or continuous estrogen regimens. Fertil Steril. 1982;37:79–82
- . Progestin replacement in the menopause: effects on the endometrium and serum lipids. Curr Opin Obstet Gynecol. 1994;6:284–292
- . Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women. Acta Obstet Gynecol Scand. 1985;64:41–46
- Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy. Lancet. 1979;2:455–457
- . Sex hormones, lipoproteins, and vascular reactivity. Curr Opin Lipidol. 1995;6:161–166
- . Effects of post-menopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: a review. Maturitas. 1990;12:259–285
- . Estrogen and interrupted progestin: a new concept for menopausal hormone replacement therapy. Am J Obstet Gynecol. 1993;168:1188–1194
-
.
Efficacy and safety of a constant estrogen, pulsed progestin regimen in hormone replacement therapy.
Int J Fertil Womens Med. 1999;
In press
-
.
Effect on 17b-estradiol/norgestimate cyclophasic hormone replacement therapy on endometrial histology [abstract].
Obstet Gynecol. 1999;93(Suppl 4):81S
- . Norgestimate. Clin Obstet Gynecol. 1995;38:841–848
- . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
- . Lp(a) lipoprotein: relationship to cardiovascular disease risk factors, exercise, and estrogen. Am J Obstet Gynecol. 1992;166:1182–1190
- . The primary prevention of coronary heart disease in women. N Engl J Med. 1995;332:1758–1766
- High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation. 1989;79:8–15
- . Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015–3023
- . Lipoprotein Lp(a) excess and coronary heart disease. Arch Intern Med. 1997;157:1170–1176
- . Triglyceride as a risk factor for coronary artery disease. Am J Cardiol. 1998;82:22Q–25Q
-
.
The emergence of triglycerides as a significant independent risk factor in coronary artery disease.
Eur Heart J. 1998;19(Suppl M):M8–M14
- . Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate. Am J Obstet Gynecol. 1994;170:1556–1561
- . Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives. Am J Med. 1991;90:584–589
☆ Supported by The R.W. Johnson Pharmaceutical Research Institute.
☆☆ Reprint requests: Rogerio A. Lobo, MD, Columbia Presbyterian Medical Center, 622 W 168th St, New York, NY 10032.
★ 0002-9378/2000 $12.00 + 0 6/1/102700
PII: S0002-9378(00)70489-3
© 2000 Mosby, Inc. All rights reserved.
« Previous
Next »
American Journal of Obstetrics & Gynecology
Volume 182, Issue 1
, Pages 41-49
, January 2000
